Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: SnowShredder who wrote (2725)	1/30/2001 9:57:18 AM
From: aknahow	Respond to of 52153

Thanks, I knew that in theory the cell expression license agreements included the ability to reproduce virus, but was not convinced it would be licensed for this purpose. The fact that XOMA itself will use its technology for this purpose makes it clear to me that the cell expresion technology can be and probably will be used for more than just production of proteins. Unfortunately even thoug over 20 licenses haqve been issued there is no way to know if the technology is being used nor do I have any idea on how XOMA itself can monitor the use of terchnology.

To: SnowShredder who wrote (2725)	1/30/2001 9:57:18 AM
From: aknahow	Respond to of 52153

Thanks, I knew that in theory the cell expression license agreements included the ability to reproduce virus, but was not convinced it would be licensed for this purpose. The fact that XOMA itself will use its technology for this purpose makes it clear to me that the cell expresion technology can be and probably will be used for more than just production of proteins. Unfortunately even thoug over 20 licenses haqve been issued there is no way to know if the technology is being used nor do I have any idea on how XOMA itself can monitor the use of terchnology.